Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05242796
Other study ID # KFMMC
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 1, 2014
Est. completion date March 1, 2016

Study information

Verified date February 2022
Source King Fahad Armed Forces Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Background: Spasticity is a major challenge in patients with cerebral palsy (CP). It may cause unwanted complications and may affect the patient's quality of life. Currently there is no satisfactory long lasting control of spasticity. Many lines of evidence indicate that magnet therapy may be a useful intervention in the management of spasticity. Several studies showed that magnet may inhibit neuronal firing in the human nervous system; however, its effects weren't studied on spasticity. Objectives: The goal of the present study was to determine the short-and long-term effects of pulsed low frequency magnetic field therapy on spasticity in patient with CP. Methods: 48 patients with CP, who have measureable level of spasticity, were selected. The sample was divided randomly into active magnet group (received magnet therapy, 32 subjects) and placebo group (16 subjects). At the end of the 4th week the magnet group was divided into two sub-groups: 1st sub-group received magnet therapy for another 4 weeks while the other received the placebo. Measurements was taken at baseline, 4th, 8th and 12th weeks. Modified Ashworth Scale was used to measure spasticity, foot pressure platform system was used to measure the contact area and the maximum force of the feet, gross motor function measure (GMFM) was used to measure the functional level of the patients. The cerebral palsy quality of life (CP-QoL) questionnaire was used to measure the patients' various dimensions of quality of life.


Recruitment information / eligibility

Status Completed
Enrollment 48
Est. completion date March 1, 2016
Est. primary completion date June 1, 2015
Accepts healthy volunteers No
Gender All
Age group 4 Years to 14 Years
Eligibility Inclusion Criteria: - A confirmed diagnosis of diplegic or quadriplegic CP of both genders, - Able to stand without assistance. - Age from 4-16 years - Measureable spasticity (1 or more according to the Modified Ashworth Scale). Exclusion Criteria: - Have recent organ transplants. - Have heart pace maker. - Have cardiac arrhythmia, tachy cardiac conditions or large aneurysm. - Have heavy psychosis. - Underwent any neuromuscular blockers of Spasticity. - Underwent any surgery of tendon lengthening before or during the study. - Have epileptic episodes.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Low frequency magnetic therapy


Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
King Fahad Armed Forces Hospital Imam Abdulrahman Bin Faisal University

Outcome

Type Measure Description Time frame Safety issue
Primary Change from baseline Modified Ashowreth Scale at 4, 8 and 12 weeks measure the muscle resistance following a passive stretch - grades from (0 - 4), lower score means better outcome baseline, 4th week, 8th week and 12th week
Primary Change from baseline Gross Motor Function Scale at 4, 8 and 12 weeks to evaluate the children with CP according to their motor functional ability - Scores (0% - 100%) where higher grade means better outcome. baseline, 4th week, 8th week and 12th week
Primary Change from baseline Feet Contact Area at 4, 8 and 12 weeks The weight distribution between the feet and the ground - Higher grade means better outcome baseline, 4th week, 8th week and 12th week
Primary Change from baseline Feet Maximum Force at 4, 8 and 12 weeks Measuring Feet Maximum Force of the participants - Higher grade means better outcome baseline, 4th week, 8th week and 12th week
Primary Change from baseline Cerebral Palsy Quality of Live Questionnaire (Social well-being and acceptance dimension) at 4, 8 and 12 weeks Items numbers in the questionnaire: (1,3,4,5,6,7,10,11,12,13,14,15).
Each item has an answer from one to nine; where 1= very unhappy, 3 = unhappy, 5 = neither happy nor unhappy, 7 = happy, and 9 = very happy.
To be calculated by summation of all the dimension's score.
Higher score means better outcome
baseline, 4th week, 8th week and 12th week
Primary Change from baseline Cerebral Palsy Quality of Live Questionnaire (Functioning dimension) at 4, 8 and 12 weeks Items numbers in the questionnaire: (8,22,23,24,27,29,34,35,37,38,39,40).
Each item has an answer from one to nine; where 1= very unhappy, 3 = unhappy, 5 = neither happy nor unhappy, 7 = happy, and 9 = very happy.
To be calculated by summation of all the dimension's score.
Higher score means better outcome
baseline, 4th week, 8th week and 12th week
Primary Change from baseline Cerebral Palsy Quality of Live Questionnaire (Participation and physical health dimension) at 4, 8 and 12 weeks Items numbers in the questionnaire: (9,16,17,18,19,20,21,25,26,30,37).
Each item has an answer from one to nine; where 1= very unhappy, 3 = unhappy, 5 = neither happy nor unhappy, 7 = happy, and 9 = very happy.
To be calculated by summation of all the dimension's score.
Higher score means better outcome
baseline, 4th week, 8th week and 12th week
Primary Change from baseline Cerebral Palsy Quality of Live Questionnaire (Emotional well-being dimension) at 4, 8 and 12 weeks Items numbers in the questionnaire: (2,28,31,32,33,52).
Each item has an answer from one to nine; where 1= very unhappy, 3 = unhappy, 5 = neither happy nor unhappy, 7 = happy, and 9 = very happy.
To be calculated by summation of all the dimension's score.
Higher score means better outcome.
baseline, 4th week, 8th week and 12th week
Primary Change from baseline Cerebral Palsy Quality of Live Questionnaire (Access to services dimension) at 4, 8 and 12 weeks Items numbers in the questionnaire: (41, 42, 43, 53, 54, 55, 56, 57, 58, 59, 60, 61).
Each item has an answer from one to nine; where 1= very unhappy, 3 = unhappy, 5 = neither happy nor unhappy, 7 = happy, and 9 = very happy.
To be calculated by summation of all the dimension's score.
Higher score means better outcome.
baseline, 4th week, 8th week and 12th week
Primary Change from baseline Cerebral Palsy Quality of Live Questionnaire (Pain and impact of disability dimension) at 4, 8 and 12 weeks Items numbers in the questionnaire: (44, 45, 46, 47, 48, 49, 50, 51).
Each item has an answer from one to nine; where (1= not bothered at all) to (9 = very bothered).
To be calculated by summation of all the dimension's score.
Higher score means worse outcome.
baseline, 4th week, 8th week and 12th week
Primary Change from baseline Cerebral Palsy Quality of Live Questionnaire (Family health dimension) at 4, 8 and 12 weeks Items numbers in the questionnaire: (62, 63, 64, 65).
Each item has an answer from one to nine; where 1= very unhappy, 3 = unhappy, 5 = neither happy nor unhappy, 7 = happy, and 9 = very happy.
To be calculated by summation of all the dimension's score.
Higher score means better outcome.
baseline, 4th week, 8th week and 12th week
Primary Comparison of Modified Ashowreth Scale scores between the three groups from baseline at 4, 8 and 12 weeks measure the muscle resistance following a passive stretch - grades from (0 - 4), lower score means better outcome baseline, 4th week, 8th week and 12th week
Primary Comparison of Gross Motor Function Scale scores between the three groups from baseline at 4, 8 and 12 weeks to evaluate the children with CP according to their motor functional ability - Scores (0% - 100%) where higher grade means better outcome. baseline, 4th week, 8th week and 12th week
Primary Comparison of Feet Contact Area scores between the three groups from baseline at 4, 8 and 12 weeks The weight distribution between the feet and the ground - Higher grade means better outcome baseline, 4th week, 8th week and 12th week
Primary Comparison of Feet Maximum Force scores between the three groups from baseline at 4, 8 and 12 weeks Measuring Feet Maximum Force of the participants - Higher grade means better outcome baseline, 4th week, 8th week and 12th week
Primary Comparison of Cerebral Palsy Quality of Live Questionnaire (Social well-being and acceptance dimension) scores between the three groups from baseline at 4, 8 and 12 weeks Items numbers in the questionnaire: (1,3,4,5,6,7,10,11,12,13,14,15).
Each item has an answer from one to nine; where 1= very unhappy, 3 = unhappy, 5 = neither happy nor unhappy, 7 = happy, and 9 = very happy.
To be calculated by summation of all the dimension's score.
Higher score means better outcome
baseline, 4th week, 8th week and 12th week
Primary Comparison of Cerebral Palsy Quality of Live Questionnaire (Functioning dimension) scores between the three groups from baseline at 4, 8 and 12 weeks Items numbers in the questionnaire: (8,22,23,24,27,29,34,35,37,38,39,40).
Each item has an answer from one to nine; where 1= very unhappy, 3 = unhappy, 5 = neither happy nor unhappy, 7 = happy, and 9 = very happy.
To be calculated by summation of all the dimension's score.
Higher score means better outcome
baseline, 4th week, 8th week and 12th week
Primary Comparison of Cerebral Palsy Quality of Live Questionnaire (Participation and physical health dimension) scores between the three groups from baseline at 4, 8 and 12 weeks Items numbers in the questionnaire: (9,16,17,18,19,20,21,25,26,30,37).
Each item has an answer from one to nine; where 1= very unhappy, 3 = unhappy, 5 = neither happy nor unhappy, 7 = happy, and 9 = very happy.
To be calculated by summation of all the dimension's score.
Higher score means better outcome
baseline, 4th week, 8th week and 12th week
Primary Comparison of Cerebral Palsy Quality of Live Questionnaire (Emotional well-being dimension) scores between the three groups from baseline at 4, 8 and 12 weeks Items numbers in the questionnaire: (2,28,31,32,33,52).
Each item has an answer from one to nine; where 1= very unhappy, 3 = unhappy, 5 = neither happy nor unhappy, 7 = happy, and 9 = very happy.
To be calculated by summation of all the dimension's score.
Higher score means better outcome.
baseline, 4th week, 8th week and 12th week
Primary Comparison of Cerebral Palsy Quality of Live Questionnaire (Access to services dimension) scores between the three groups from baseline at 4, 8 and 12 weeks Items numbers in the questionnaire: (41, 42, 43, 53, 54, 55, 56, 57, 58, 59, 60, 61).
Each item has an answer from one to nine; where 1= very unhappy, 3 = unhappy, 5 = neither happy nor unhappy, 7 = happy, and 9 = very happy.
To be calculated by summation of all the dimension's score.
Higher score means better outcome.
baseline, 4th week, 8th week and 12th week
Primary Comparison of Cerebral Palsy Quality of Live Questionnaire (Pain and impact of disability dimension) scores between the three groups from baseline at 4, 8 and 12 weeks Items numbers in the questionnaire: (44, 45, 46, 47, 48, 49, 50, 51).
Each item has an answer from one to nine; where (1= not bothered at all) to (9 = very bothered).
To be calculated by summation of all the dimension's score.
Higher score means worse outcome.
baseline, 4th week, 8th week and 12th week
Primary Comparison of Cerebral Palsy Quality of Live Questionnaire (Family health dimension) scores between the three groups from baseline at 4, 8 and 12 weeks Items numbers in the questionnaire: (62, 63, 64, 65).
Each item has an answer from one to nine; where 1= very unhappy, 3 = unhappy, 5 = neither happy nor unhappy, 7 = happy, and 9 = very happy.
To be calculated by summation of all the dimension's score.
Higher score means better outcome.
baseline, 4th week, 8th week and 12th week
See also
  Status Clinical Trial Phase
Recruiting NCT05571033 - Operant Conditioning of the Soleus Stretch Reflex in Adults With Cerebral Palsy N/A
Completed NCT00011024 - Prospective Studies of the Use of Self Hypnosis, Acupuncture and Osteopathic Manipulation on Muscle Tension in Children With Spastic Cerebral Palsy Phase 2
Recruiting NCT05810779 - Dynamic Surface Exercise and Trunk Targeted Training in Children With Spastic Cerebral Palsy N/A
Completed NCT01049581 - Effects of Pediatric Aquatic Therapy in Children With Spastic Cerebral Palsy N/A
Completed NCT04634136 - Full-spectrum Medical Cannabis for Treatment of Spasticity in Patients With Severe Forms of Cerebral Palsy N/A
Recruiting NCT06070233 - Radiosurgery Treatment for Spasticity Associated With Stroke, SCI & Cerebral Palsy N/A
Completed NCT01815814 - Therapeutic Potential of Myofascial Structural Integration in Children With Cerebral Palsy N/A
Recruiting NCT05113433 - Effects of Different Time Period of Standing Frame on Spasticity and Gait in Children With Spastic Cerebral Palsy. N/A
Recruiting NCT03676439 - Lateral Cord Magnetic Stimulation For Refractory Spastic Cerebral Palsy Phase 2/Phase 3
Completed NCT03708757 - Effect of Post Isometric Relaxation Technique & Eccentric Muscle Contraction on Hamstring Spasticity in CP N/A
Not yet recruiting NCT03529682 - Circuit Training in Children With Cerebral Palsy N/A
Not yet recruiting NCT06407856 - Dual Task Training in Spastic Cerebral Palsy N/A
Not yet recruiting NCT06407869 - Effects of Functional Progressive Strength Training in Children With Spastic Cerebral Palsy N/A
Not yet recruiting NCT06407921 - Whole Body Vibration and BOSU Ball in Spastic Cerebral Palsy N/A
Completed NCT04078321 - Evaluation of Multifocal Transcutaneous Electrical Stimulation for Self-treatment Among Children With Cerebral Palsy N/A
Active, not recruiting NCT06330311 - Effectiveness of Whole-Body Vibration N/A
Terminated NCT00955877 - Extended-release Epidural Morphine for Acute Post-operative Analgesia Following Selective Dorsal Rhizotomy in Children N/A
Completed NCT02359799 - Robotic Rehabilitation of Cerebral Palsy N/A
Not yet recruiting NCT05340439 - INcobotulinumtoxina in ChIldren Upper and Lower Limb sPasticITy (INCIPIT) Phase 2
Completed NCT01147653 - A Randomized Study of Autologous Umbilical Cord Blood Reinfusion in Children With Cerebral Palsy Phase 2